Sarcopenia has been established as a predictor of poor outcomes in various clinical
settings. It is particularly prevalent in heart failure, a clinical syndrome that poses significant …

Sarcopenia is prevalent in patients with chronic liver disease, and affected patients tend to
have worse clinical outcomes and higher mortality. However, relevant analyses are limited …

Abstract Background Context Sarcopenia measured by psoas muscle index (PMI) has been
shown to predict perioperative mortality and adverse events (AEs) after various surgical …

Summary Background The European Society for Clinical Nutrition and Metabolism (ESPEN)
and the European Association for the Study of Obesity (EASO) recently released the first …

Background: Muscle quality is associated with fatty degeneration or infiltration of the muscle,
which may be associated with decreased muscle function and increased disability …

Background Measuring muscle mass and muscle quality based on chest Computed
Tomography (CT) images would facilitate sarcopenia and myosteatosis research. We aimed …

Background Although computed tomography (CT) is considered the gold standard for
investigating skeletal muscles, diagnostic cutoff points for sarcopenia have not been …

Rationale and Objectives Skeletal muscle mass measurement is the most important element
for diagnosing sarcopenia. MRI has an excellent soft-tissue contrast, which can non …

Background Manual muscle mass assessment based on Computed Tomography (CT) scans
is recognized as a good marker for malnutrition, sarcopenia, and adverse outcomes …

Introduction Low creatinine to cystatin-C ratio (Cr/Cys-C) may be a biomarker for low-muscle
mass. Furthermore, low Cr/Cys-C is associated with decreased overall survival (OS), but to …